文献速递肺血管病与心包/心肌炎血脂与心血管预防

乳腺癌揭示BMPR2相关肺动脉高压易感性

Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
PubMed 文献 · Circulation · 2026-01-28

该研究结合生物信息学、流行病学与实验手段,探讨BMPR2缺陷如何连接乳腺癌与肺动脉高压(PAH)。在Bmpr2+/Δ71雌性大鼠中,乳腺癌发生可加重肺动脉高压及血管重构与炎症;法国国家医疗数据库显示乳腺癌与PAH存在双向关联。结论提示乳腺癌可作为「二次打击」暴露BMPR2相关PAH易感性。

要点

  • BMPR2缺陷的雌性大鼠可自发乳腺肿瘤,并加重肺动脉高压与肺血管重构。
  • 肿瘤条件培养基通过IL-1β依赖信号促BMPR2突变肺动脉平滑肌细胞增殖。
  • PAH患者乳腺癌发病率较一般人群高一倍以上,乳腺癌患者PAH发病率升高近9倍。

核心结论

  • 乳腺癌与PAH存在由BMPR2信号缺陷及肿瘤相关炎症介导的双向关联。
  • 乳腺癌可能作为「二次打击」暴露BMPR2相关的PAH易感性。

研究设计与样本

  • 研究结合生物信息学分析、流行病学数据库分析与体内外实验。
  • 体内使用雌性Bmpr2+/Δ71大鼠,给予或不给予7,12-二甲基苯并[a]蒽暴露。
  • 流行病学部分分析法国国家医疗数据库中的9964例PAH患者。

主要发现

  • 人乳腺癌组织中BMPR2表达显著降低,并发现反复出现的体细胞变异与深度缺失。
  • Bmpr2+/Δ71大鼠自发乳腺肿瘤,经7,12-二甲基苯并[a]蒽暴露后肺动脉高压加重,伴血管重构与炎症增加。
  • 荷瘤Bmpr2+/Δ71大鼠肺内IL-1β升高且NF-κB活化。
  • Bmpr2+/Δ71肿瘤条件培养基经IL-1β依赖信号促Bmpr2+/Δ71肺动脉平滑肌细胞增殖,中和IL-1β可减弱该效应。
  • 携带BMPR2突变的人肺动脉平滑肌细胞同样对IL-1β诱导的增殖反应增强。

关键数值与推荐

  • PAH患者中乳腺癌发病率较一般人群高一倍以上。
  • 乳腺癌患者中PAH发病率升高近9倍。

临床怎么用

  • 对乳腺癌患者应关注PAH相关症状,对PAH患者也应关注乳腺癌筛查。
  • BMPR2突变携带者可能需加强乳腺癌与PAH的监测。
  • IL-1β信号或为BMPR2缺陷相关PAH的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone morphogenetic protein receptor type 2) mutations, the most common genetic cause of heritable PAH, also exert tumor-suppressive functions, but their role in linking these diseases remains unclear. METHODS: We combined bioinformatic, epidemiologic, and experimental approaches. Public cancer datasets were mined for BMPR2 alterations. In vivo, mammary tumor development and pulmonary hemodynamics were assessed in female Bmpr2+/Δ71 rats with or without carcinogen (7,12-dimethylbenz[a]anthracene) exposure. Pulmonary arterial smooth muscle cells were exposed to tumor-conditioned media to test inflammatory proliferation. Finally, associations between breast cancer and PAH were examined in the French National Healthcare Database (9964 patients with PAH). RESULTS: BMPR2 expression was markedly reduced in human breast tumors, with recurrent somatic variants and deep deletions identified. Bmpr2+/Δ71 rats exhibited spontaneous mammary tumors and, following 7,12-dimethylbenz[a]anthracene exposure, developed exacerbated pulmonary hypertension with increased vascular remodeling and inflammation. Tumor-bearing Bmpr2+/Δ71 rats showed elevated lung IL-1β and NF-κB activation. In vitro, conditioned media from Bmpr2+/Δ71 tumors induced proliferation of Bmpr2+/Δ71 pulmonary arterial smooth muscle cells via IL-1β-dependent signaling, while neutralization of IL-1β attenuated this effect. Human pulmonary arterial smooth muscle cells carrying BMPR2 mutations similarly displayed heightened IL-1β-induced proliferation. Epidemiologically, breast cancer incidence was more than doubled in patients with PAH compared with the general population, and PAH incidence was increased nearly 9-fold among patients with breast cancer, indicating a bidirectional relationship. CONCLUSIONS: These findings identify a reciprocal association between breast cancer and PAH mediated by defective BMPR2 signaling and tumor-associated inflammation. Breast cancer may act as a "second hit," unmasking BMPR2-related susceptibility to PAH, underscoring BMPR2 as a shared molecular vulnerability with implications for surveillance of at-risk populations.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Toro V, Mougin M, Brossat C, et al. Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension. Circulation. 2026. PMID: 41603037. doi:10.1161/CIRCULATIONAHA.125.079067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。